CBT Stock Analysis: Buy, Sell, or Hold?
CBT - Cabot Corporation
$75.51
1.40 (1.89%)
▲
5d:
+10.3%
30d:
-0.83%
90d:
+13.57%
BUY
MODERATE Confidence
Analysis Updated: Mar 30, 2026 12:00 AM ET
Earnings: May 04, 2026
Get Alerted When CBT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: CBT shows positive signals but monitor for confirmation. Market pricing in 3.6% growth. Moderate conviction.
💡 BUY OPPORTUNITY: CBT shows positive signals but monitor for confirmation. Market pricing in 3.6% growth. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$95.37
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$59.21
Trading above fair value
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 9.9x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: CBT is currently trading at $75.51, which is considered extended relative to its 30-day fair value range of $69.00 to $75.31. From a valuation perspective, the stock is trading at a premium (Forward PE: 11.0) compared to its historical average (9.9). At these levels, the market is pricing in 3.6% annual earnings growth.
Technical Outlook: Technically, CBT is in a strong uptrend. The price is approaching resistance at $75.42. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: CBT has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (20th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, CBT is in a strong uptrend. The price is approaching resistance at $75.42. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: CBT has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (20th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$69.00 -
$75.31
Company Quality Score
54/100
(HOLD)
Options IV Signal
20th percentile
(COMPLACENCY WARNING)
Volume Confirmation
HIGH
Confidence Score
68.1%
All Signals
- BEARISH: Price extended above range
- BULLISH: Options cheap (IV 20th percentile)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($77.80)
- BULLISH: Expecting earnings turnaround to 3.6% growth with -11.1% revenue growth
Fair Price Analysis
30-Day Fair Range
$69.00 -
$75.31
Current vs Fair Value
EXTENDED
Expected Move (7 Days)
±$3.26
(4.3%)
Support & Resistance Levels
Support Level
$66.61
Resistance Level
$75.42
Current Trend
Strong Uptrend
Technical data as of
Mar 30, 2026
Fundamental Context
Forward P/E (Next Year Est.)
11.01
Wall Street Target
$77.80
(+3.0%)
Revenue Growth (YoY)
-11.1%
Earnings Growth (YoY)
-18.2%
Profit Margin
8.6%
Valuation Premium vs History
+3.6% premium
PE vs Historical
11.0 vs 9.9
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+3.6%
(market-implied from PE analysis)
1-Year Target
$78.23
(+4%)
2-Year Target
$81.04
(+7%)
3-Year Target
$83.96
(+11%)
3-Yr Target (if PE normalizes)
(PE: 11→10)
PE COMPRESSION
$75.51
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.4, Growth: 10.1%)
$204.59
(+171%)
Base:
(SPY PE: 11.0, Growth: 10.1%)
$100.77
(+34%)
Bear:
(PE: 9.4, Growth: 10.1%)
$85.66
(+13%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (12x PE), but valuation improves significantly next year (11x PE) as earnings recover.
Trailing PE: 11.86 | Current EPS (TTM): $5.72
Bull Case
$89.46
(+31%)
Analyst growth 19.9%, PE expands to 13.0
Base Case
$81.33
(+19%)
Market implied 19.9%, PE stable at 11.9
Bear Case
$46.12
(-33%)
Severe decline -20.0%, PE contracts to 10.1
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: March 30, 2026 8:53 PM ET
Data refreshes hourly during market hours. Next update: 9:53 PM
Data refreshes hourly during market hours. Next update: 9:53 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CBT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Specialty Chemicals Stocks
Top-rated stocks in Specialty Chemicals by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LIN
Linde plc Ordinary Shares |
BUY
28 analysts |
$516 | 58 HOLD |
|
SHW
Sherwin-Williams Co |
BUY
28 analysts |
$388 | 64 BUY |
|
IFF
International Flavors & … |
STRONG BUY
22 analysts |
$91 | 65 BUY |
|
APD
Air Products and Chemica… |
BUY
24 analysts |
$308 | 63 BUY |
|
DD
Dupont De Nemours Inc |
STRONG BUY
20 analysts |
$53 | 57 HOLD |
